Author: scribeofegypt@gmail.com

Infograph: VV vs. VA ECMO

scribeofegypt@gmail.com infographs , ,

VV vs VA ECMOInfograph: VV vs. VA ECMO

ECMO (Extracorporeal Membrane Oxygenation) comes in two main configurations, each serving distinct clinical purposes.

Core Function

VV ECMO provides isolated pulmonary support, handling only gas exchange (oxygenation and CO₂ removal) without any circulatory assistance. VA ECMO provides dual heart and lung support, acting as an extracorporeal right-to-left shunt that unloads a failing heart while maintaining organ perfusion.

Native Cardiac Requirement

This is a critical distinction — VV ECMO requires a functioning heart to pump oxygengenated blood through the body, whereas VA ECMO can drive circulation independently of heart function, making it suitable for patients in cardiac failure.

Cannulation Pathway

VV ECMO uses a venous-to-venous path, returning blood to the venous system. It can use two sites or a single specialized double-lumen cannula (often in the neck), making it surgically simpler. VA ECMO uses a venous-to-arterial path, returning blood to a large artery (femoral or aorta), bypassing both heart and lungs.

Clinical Indications

VV ECMO is used for severe ARDS, pneumonia, and trauma when mechanical ventilation has failed. VA ECMO is indicated for cardiac arrest (E-CPR), refractory cardiogenic shock, and as a bridge to heart transplantation.

Unique Risks

VV ECMO carries the risk of recirculation, where oxygenated blood is pulled back into the circuit before completing systemic circulation, typically from cannula malposition. VA ECMO carries a significant risk of limb ischemia (10–70%) due to arterial cannulation, plus a “watershed phenomenon” that can impair brain oxygenation.

A Nutritional Guide for COPD Management

scribeofegypt@gmail.com infographs ,

A Nutritional Guide for COPD Management

Fueling-Your-Breath-A-Nutritional-Guide-for-COPD-Management

COPD & Nutrition Connection

COPD worsens nutritional status, and malnutrition in turn aggravates the disease — creating a harmful cycle. There are two common patient profiles: Pink Puffers (very thin/cachectic) and Blue Bloaters (frequently obese), each with different nutritional needs.

Undernutrition dangers include decreased diaphragmatic strength, increased shortness of breath, diminished mobility, and higher healthcare costs. Obesity reduces lung function and increases systemic inflammation.

Nutritional Goals for Undernourished Patients

  • 35–45 kcal/kg of body weight per day
  • 1.2g of protein/kg of body weight per day, focusing on essential amino acids
  • Increasing muscle mass (not just weight) is a strong predictor of improved survival

✅ Dietary Dos

  • Antioxidant-rich fruits & vegetables — reduce COPD risk and oxidative stress
  • High-fiber foods — linked to better lung function
  • Omega-3 fatty acids — anti-inflammatory and cardiovascular benefits
  • Creatine — combined with exercise, increases muscle mass and strength
  • Nitrates from vegetables — improve vascular function and relax airway muscles
  • Polyphenols & Flavonoids — antioxidant and immune-modulating properties
  • Probiotics — support gut health, which is linked to lung health and reduced inflammation

❌ Dietary Don’ts

  • Processed red meat — linked to increased COPD risk and decreased lung function
  • Harmful additives & fats — preservatives, saturated fats, and color additives promote systemic inflammation
  • Nitrates from cured meats — form carcinogenic nitrosamines, contributing to COPD severity

Key Vitamins for COPD Management

Vitamin Role
A Tissue repair, immune function, alveolar development
B Energy metabolism, muscle function, DNA repair
C Antioxidant defense; smokers need up to 200mg/day
D Anti-inflammatory; regulates cytokines; deficiency is common
E γ-tocopherol form has superior anti-inflammatory effects
K Lung elasticity; K2 maintains lung tissue integrity; deficiency lowers lung function

Key Takeaway

Managing COPD nutritionally means eating to fight inflammation, protect lung tissue, and preserve muscle mass — while avoiding processed and cured meats, harmful fats, and additives that worsen inflammation and disease progression.

Highlights from Cairo Garment Week 2025

scribeofegypt@gmail.com textile , , ,

Highlights from Cairo Garment Week 2025

Cairo-garment-Week-2025-Egypt-TextilesCairo Garment Week (CGW) 2025 is the Egyptian garment industry’s premier event, which was held at the Cairo International Conference Center (CICC) in Nasr City from 4 till 7 December , 2025.

Co-organized by Vision Fairs and Scribe, the event brings together the brightest minds in fashion design, textile technology, digital manufacturing, and garment production under one roof.

Running in parallel with the Egypt Stitch & Tex – Garment Technologies Exhibition, CGW 2025 is built around four thematic days, each addressing a distinct dimension of the modern garment industry: design, digital transformation, knitted fabrics, and printing technologies.

Scribe plays a central role as co-organizer of Cairo Garment Week 2025, contributing its expertise in knowledge management, content curation, and symposium design. Scribe’s hallmark is its ability to structure complex industry knowledge into coherent, actionable learning experiences. Its involvement ensures that CGW 2025 goes beyond a traditional trade fair, delivering a rigorous intellectual and professional program that equips attendees with practical skills, strategic insights, and meaningful industry connections.

Mohamed-Samy-Cairo-Garment-Week-egypt.

Dr Mahmoud Abbas and Zeki Perdi Cairo Garment Week

Cairo-Garment-Week-Egypt-Foil-printing

The Heart-Lung Crosstalk: Managing Right Ventricular Strain In ARDS 

scribeofegypt@gmail.com infographs , , ,

The Heart-Lung Crosstalk: Managing Right Ventricular Strain In ARDS

Lung Heart Crosstalk Managing Right Ventricle Strain in ARDS Core Pathophysiological Cascade

The infographic traces a clear cause-and-effect chain: it begins with an initial lung insult (pathogen/trauma) triggering cytokines (IL-6, TNF-α), which damages the alveolar-capillary barrier. This leads to Pulmonary Vascular Dysfunction (PVD) — hypoxia, hypercapnia, and inflammation converge to raise pulmonary artery pressure through vasoconstriction and microvascular thrombosis.

The resulting Increased RV Afterload & Strain forces the right ventricle to pump against a high-resistance circuit, risking ischemia and dysfunction — the central problem the entire infographic addresses.

The “Double-Edged Sword” Insight

One of the most striking conceptual titles is “The Double-Edged Sword of Ventilation.” This highlights a critical clinical paradox: the very intervention used to treat ARDS (mechanical ventilation with high PEEP) can worsen RV strain by increasing intrathoracic pressure, compromising venous return and heart output. Treatment itself becomes a threat.

The Mortality Stakes

The 60-70% mortality rate headline is a sobering anchor. ARDS patients who progress to overt RV failure with Acute Cor Pulmonale face dramatically worse outcomes, justifying the aggressive monitoring and management strategies described.

Monitoring Strategy: Two Complementary Tools

The Advanced Bedside Monitoring section presents two approaches working in tandem — Electrical Impedance Tomography (EIT) for real-time, non-invasive lung-perfusion monitoring, and Critical Care Echocardiography as the gold standard for detecting RV dilation (RV/LV diameter ratio threshold >0.6). Together they address both pulmonary and cardiac dimensions of the problem.

The RV Protective Strategy: Four Pillars

The management section is organized around four distinct interventions, each targeting a different mechanism:

  • Prone Positioning — mechanical redistribution of lung ventilation to unload the RV
  • “Safe” Plateau Pressure (≤27 cmH₂O) — limiting ventilator-induced barotrauma
  • VV-ECMO — bypassing the lung entirely in severe cases to eliminate ventilator strain
  • Hemodynamic Support (norepinephrine + fluid restriction) — preserving RV perfusion pressure without volume overload

Key Conceptual Insight

The overarching theme is bidirectionality — the heart and lungs don’t fail independently in ARDS. Every intervention in one system ripples into the other, demanding an integrated “heart-lung crosstalk” mindset rather than organ-siloed management.

Beyond Asthma : The Clinical Versatility of FeNO Testing

scribeofegypt@gmail.com infographs , , ,

Beyond Asthma : The Clinical Versatility of FeNO Testing

Beyond Asthma -Clinical Versatility of FeNO

What is FeNO? Fractional exhaled Nitric Oxide (FeNO) is a non-invasive biomarker used to detect, monitor, and screen airway inflammation across a wide range of conditions — not just asthma.

Relevance to Asthma (Core Application)

While the infographic highlights FeNO’s versatility, its asthma-related utility remains central:

  • Monitoring Treatment Response — FeNO helps assess a patient’s adherence to inhaled corticosteroids (ICS) and guides ongoing steroid therapy decisions. Elevated FeNO in a patient on ICS may signal poor adherence or inadequate dosing.
  • Eosinophilic Inflammation — Elevated FeNO levels indicate eosinophilic airway inflammation, which directly guides anti-inflammatory treatment choices in asthma management.
  • Steroid-Responsive Phenotyping — In overlapping conditions like COPD, FeNO helps identify patients whose inflammatory profile resembles asthma and are likely to benefit from corticosteroids.

Broader Clinical Versatility

Condition FeNO Characteristic Clinical Value
Eosinophilic Inflammation Elevated Guides anti-inflammatory therapy
COPD & Chronic Cough Variable Identifies steroid-responsive phenotypes
Primary Ciliary Dyskinesia Very low/Absent Supports PCD diagnosis
Allergic/Atopic Conditions Elevated Detects eosinophilic inflammation in rhinitis & dermatitis
Occupational Screening Variable Screens for occupational asthma
Systemic Research Variable Links to hypertension & diabetes

Key Takeaway

FeNO is most established as an asthma management tool — particularly for guiding steroid therapy and confirming eosinophilic inflammation — but its utility is expanding into occupational health, rare diseases like PCD, and systemic disease research, making it a highly versatile non-invasive clinical tool.

Metabolic Powerhouses: GLP-1 RAs and SGLT2 Inhibitors

scribeofegypt@gmail.com Scribe medical conferences Egypt , ,

Metabolic Powerhouses: GLP-1 RAs and SGLT2 Inhibitors

Metabolic Powerhouses GLP-1 RAs and SGLT2 Inhibitors

GLP-1 Receptor Agonists (GLP-1 RA) — The Brain-Gut Connection

Mechanism: Mimics the natural incretin hormone GLP-1 to regulate metabolism and appetite.

Key Effects:

Mimicking Incretin Hormones — Functions like endogenous GLP-1 to regulate metabolism and appetite. ✅ Accurate — GLP-1 RAs are synthetic analogs of GLP-1.

Brain-Gut Connection — Increases satiety and slows gastric emptying, reducing caloric intake. ✅ Accurate — well-documented CNS and GI effects.

High Weight Loss Potency — Targets hunger and appetite suppression via agents like semaglutide and tirzepatide. ⚠️ Mostly accurate, but tirzepatide is a dual GIP/GLP-1 agonist, not a pure GLP-1 RA — a meaningful distinction.

Pancreatic Regulation — Stimulates glucose-dependent insulin secretion while suppressing glucagon. ✅ Accurate — the glucose-dependent nature is a key safety advantage.

SGLT2 Inhibitors (SGLT2i) — Kidney-Focused Regulation

Mechanism: Works through the kidneys, independent of insulin signaling.

Key Effects:

Kidney-Focused Regulation — Acts on renal proximal tubules independently of insulin. ✅ Accurate.

Glucosuria (Glucose Excretion) — Blocks glucose reabsorption in proximal tubules, flushing out excess glucose. ✅ Accurate — this is the core mechanism.

Modest Caloric Loss — Achieves weight loss via direct caloric loss through urine. ✅ Accurate, though weight loss is modest compared to GLP-1 RAs (typically 2–4 kg).

Fluid and Pressure Control — Lowers blood pressure through osmotic diuresis and natriuresis. ✅ Accurate — a well-established cardiovascular benefit.

Synergistic Metabolic Effects (Combined Therapy)

Additive Clinical Benefits — Combining GLP-1 RA and SGLT2i targets multiple metabolic pathways simultaneously. ✅ Supported by emerging clinical evidence.

Diverse Treatment Pathways — One drug class addresses appetite and insulin; the other addresses glucose excretion and fluid balance. ✅ Accurate and complementary mechanisms.

Long-term Health Protection — Combination therapy is associated with reduced risks of kidney failure and major cardiovascular events. ✅ Supported by trials like EMPA-REG, LEADER, and CANVAS, though large dedicated combination trials are still ongoing.

Scribe to organize ECMO Experts Made Easy Course

scribeofegypt@gmail.com critical care , , ,

ECMO-January-26-Egypt-Critical-CareScribe to organize ECMO Experts Made Easy Course

The Egyptian ECMO Working Group (A Division of ECCCP ) is orrganizing a 3 days course from 29 till 31 January, 2026 at the Critical Care Departement, Cairo University.  

What the course will offer:

ECMO Skills:

  • VV and VA ECMO modes, physiology, and circuit management
  • Cannulation techniques and troubleshooting
  • ARDS and cardiac failure management
  • ECPR and emergency protocols

Advanced Clinical Practice:

  • Mechanical ventilation strategies on ECMO
  • Medication management and monitoring
  • ECMO weaning and transport
  • Complications and emergency response

Interactive Learning Experience

✓ Expert-Led Sessions – Learn from Prof. Akram Abdel Bary and experienced faculty
✓ Hands-On Training – Extensive simulation stations and practical scenarios
✓ Real-World Cases – Multiple case simulations and troubleshooting exercises
✓ Comprehensive Assessment – Pre and post-testing with certification

Course Highlights

  • Circuit priming and de-airing practice
  • Oxygenator failure management
  • Accidental decannulation scenarios
  • Console operation training
  • Multidisciplinary care coordination

Perfect for: Critical care physicians, intensivists, perfusionists, and ECMO team members seeking to build or enhance their ECMO expertise.

Cairo Garment Week Program

scribeofegypt@gmail.com textile , , ,

Cairo-Garment-Week-2025-Scribe-conferences-Egypt.jCairo Garment Week Program

Cairo Garment Week program includes an extraordinary four-day symposia that provide the latest knowldge about fashion design, garment manufacturing and digital transformation.

Symposia are:

December 4, 2025 : From Everyday to Elegant

Immerse yourself in the complete garment design journey—from creative concepts to final stitches. Explore casual wear, professional business attire, and Fashion QR’s cultural fusion approach. Plus, discover how to build effective designer-manufacturer partnerships that bridge creativity with production reality.

December 5, 2025 : Digital Threads & Cairo Denim Day

Witness the digital revolution transforming garment manufacturing. Learn about AI-powered transformations, automation pathways, and Industry 4.0 upskilling. Cap the day with Cairo Denim Day 2025, exploring the latest trends and innovations in this timeless fabric.

December 6, 2025 : Knitted Fabrics Innovation

Dive deep into warp and weft knitting techniques, seamless technology, quality control standards, and sustainable production methods. From technical understanding to market-ready applications, this day covers the complete knit fabric ecosystem.

December 7, 2025 : Printing Excellence on Knitted Fabrics

Master the art and science of printing on knitted fabrics. From setting up printing houses to achieving print excellence through fabric treatment, DTF technology, sublimation techniques, and AI-generated patterns for Spring/Summer 2026.

Great Succes for the Third Egyptian Spanish Critical Care Summit

scribeofegypt@gmail.com Scribe medical conferences Egypt , , ,

Great Succes for the Third Egyptian Spanish Critical Care Summit

Critical-care-Conference-Egypt-

Held on the 1st and 2nd of October , 2025 , the third Egyptian Spanish Critical Care Summit was held at Assiut University, Assiut, Egypt. The summit was co-organized by the Egyptian College of Critical Care Physicians – ECCCP- and The Spanish Intensive care Society -SEMICYUC.

The summit program featured lectures presented by both Egyptian and Spanish faculty.

From SEMICYUC , Dr Fernando Sipmann and Dr Oscar Penuelas, Chairman and Vice Chairman of SEMICYUC Scientific Committee presented the following lectures:

  • Importance of Heart-Lung Interactions and Pulmonary Vascular Dysfunction in ARDS, Fernando Suarez Sipmann, Hospital Universitario de la Princesa, Madrid 
  • How to Manage Difficult to Wean Patients?, Oscar Peñuelas Rodriguez, Hospital Universitario de Getafe, Madrid
  • Use of Electrical Impedance Tomography to individualize Mechanical Ventilation, Fernando Suarez Sipmann, Hospital Universitario de la Princesa, Madrid 
  • Steroids in ARDS: Is there still a Role? Oscar Peñuelas Rodriguez, Hospital Universitario de Getafe, Madrid

Visiting Texhibition İstanbul in Preparation of Cairo Garment Week

scribeofegypt@gmail.com digital textile printing, textile , ,

Visiting Texhibition İstanbul in Preparation of Cairo Garment Week

Dr-Mahmoud-Abbas-Textiles-Egypt-exhibitionIn prepartion of Cairo Garment Week to be held from 4 till 7 December , 2025 at CICC, Cairo, Egypt , Dr Mahmoud Abbas visited Texhibition İstanbul in Turkey.

The exhibition feautered the latest fabric innovations manufactured by Turkish companies.

Cairo Garment Week will run over 4 days featuring the latest knowledge in garment manufacturing as well as fashion trends.

With special focus on knitted fabrics , two symposia will cover the knitted fabric properties and also how to print on them.